Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 3
2002 17
2003 12
2004 19
2005 17
2006 27
2007 45
2008 62
2009 76
2010 83
2011 122
2012 151
2013 199
2014 322
2015 359
2016 436
2017 502
2018 581
2019 661
2020 860
2021 999
Text availability
Article attribute
Article type
Publication date

Search Results

4,882 results
Results by year
Filters applied: . Clear all
Page 1
Clinical Perspective and Translational Oncology of Liquid Biopsy.
Fernández-Lázaro D, Hernández JLG, García AC, Castillo ACD, Hueso MV, Cruz-Hernández JJ. Fernández-Lázaro D, et al. Diagnostics (Basel). 2020 Jun 30;10(7):443. doi: 10.3390/diagnostics10070443. Diagnostics (Basel). 2020. PMID: 32629823 Free PMC article. Review.
Currently, LB has been shown to be effective for its application in different types of tumors including lung, colorectal, prostate, melanoma, breast and pancreatic cancer, by the determination and identification of biomarkers that with a high probability have the potential to cha …
Currently, LB has been shown to be effective for its application in different types of tumors including lung, colorectal, prostate, melanoma …
mRNA-based therapeutics--developing a new class of drugs.
Sahin U, Karikó K, Türeci Ö. Sahin U, et al. Nat Rev Drug Discov. 2014 Oct;13(10):759-80. doi: 10.1038/nrd4278. Epub 2014 Sep 19. Nat Rev Drug Discov. 2014. PMID: 25233993 Review.
Advances in addressing the inherent challenges of this drug class, particularly related to controlling the translational efficacy and immunogenicity of the IVTmRNA, provide the basis for a broad range of potential applications. mRNA-based cancer immunotherapies and infecti …
Advances in addressing the inherent challenges of this drug class, particularly related to controlling the translational efficacy and …
An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma.
Sahin U, Oehm P, Derhovanessian E, Jabulowsky RA, Vormehr M, Gold M, Maurus D, Schwarck-Kokarakis D, Kuhn AN, Omokoko T, Kranz LM, Diken M, Kreiter S, Haas H, Attig S, Rae R, Cuk K, Kemmer-Brück A, Breitkreuz A, Tolliver C, Caspar J, Quinkhardt J, Hebich L, Stein M, Hohberger A, Vogler I, Liebig I, Renken S, Sikorski J, Leierer M, Müller V, Mitzel-Rink H, Miederer M, Huber C, Grabbe S, Utikal J, Pinter A, Kaufmann R, Hassel JC, Loquai C, Türeci Ö. Sahin U, et al. Nature. 2020 Sep;585(7823):107-112. doi: 10.1038/s41586-020-2537-9. Epub 2020 Jul 29. Nature. 2020. PMID: 32728218 Clinical Trial.
From Puppy to Patient: Translational Oncology.
Cohen JV. Cohen JV. JAMA Intern Med. 2019 Jan 1;179(1):7-8. doi: 10.1001/jamainternmed.2018.5464. JAMA Intern Med. 2019. PMID: 30419090 No abstract available.
PLK1, A Potential Target for Cancer Therapy.
Liu Z, Sun Q, Wang X. Liu Z, et al. Transl Oncol. 2017 Feb;10(1):22-32. doi: 10.1016/j.tranon.2016.10.003. Epub 2016 Nov 24. Transl Oncol. 2017. PMID: 27888710 Free PMC article. Review.
Cancer biology.
Cree IA. Cree IA. Methods Mol Biol. 2011;731:1-11. doi: 10.1007/978-1-61779-080-5_1. Methods Mol Biol. 2011. PMID: 21516393 Review.
Optimising translational oncology in clinical practice: strategies to accelerate progress in drug development.
Stahel R, Bogaerts J, Ciardiello F, de Ruysscher D, Dubsky P, Ducreux M, Finn S, Laurent-Puig P, Peters S, Piccart M, Smit E, Sotiriou C, Tejpar S, Van Cutsem E, Tabernero J. Stahel R, et al. Cancer Treat Rev. 2015 Feb;41(2):129-35. doi: 10.1016/j.ctrv.2014.12.004. Epub 2014 Dec 16. Cancer Treat Rev. 2015. PMID: 25533737 Free article. Review.
A number of molecular screening platforms have already been initiated across Europe, and it is hoped that these networks, along with future collaborations, will benefit not only patients but also society through cost reductions as a result of more efficient use of resources. This …
A number of molecular screening platforms have already been initiated across Europe, and it is hoped that these networks, along with future …
Models in Translational Oncology: A Public Resource Database for Preclinical Cancer Research.
Galuschka C, Proynova R, Roth B, Augustin HG, Müller-Decker K. Galuschka C, et al. Cancer Res. 2017 May 15;77(10):2557-2563. doi: 10.1158/0008-5472.CAN-16-3099. Cancer Res. 2017. PMID: 28507049 Free article. Review.
The devastating diseases of human cancer are mimicked in basic and translational cancer research by a steadily increasing number of tumor models, a situation requiring a platform with standardized reports to share model data. Models in Translational Oncology
The devastating diseases of human cancer are mimicked in basic and translational cancer research by a steadily increasing number of t …
Genomics of Helicobacter pylori.
Thorell K, Lehours P, Vale FF. Thorell K, et al. Helicobacter. 2017 Sep;22 Suppl 1. doi: 10.1111/hel.12409. Helicobacter. 2017. PMID: 28891132 Review.
Major milestones in translational oncology.
Dragani TA, Castells A, Kulasingam V, Diamandis EP, Earl H, Iams WT, Lovly CM, Sedelaar JP, Schalken JA. Dragani TA, et al. BMC Med. 2016 Jul 28;14(1):110. doi: 10.1186/s12916-016-0654-y. BMC Med. 2016. PMID: 27469586 Free PMC article.
Translational oncology represents a bridge between basic research and clinical practice in cancer medicine. Today, translational research in oncology benefits from an abundance of knowledge resulting from genome-scale studies regarding the molecular pa
Translational oncology represents a bridge between basic research and clinical practice in cancer medicine. Today, translat
4,882 results